메뉴 건너뛰기




Volumn , Issue , 2014, Pages 115-144

Ovarian cancer standards of care

Author keywords

Epithelial tumours; Germ cell tumours; Interval debulking surgery; Intraperitoneal chemotherapy; Lymphadenectomy; Non epithelial ovarian neoplasms; Ovarian cancer; Ovarian carcinoma; Radiotherapy; Sex cord stromal tumours

Indexed keywords


EID: 84901459152     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139696951.011     Document Type: Chapter
Times cited : (1)

References (49)
  • 1
    • 34548277030 scopus 로고    scopus 로고
    • Survival for eight major cancers and all cancers combined for european adults diagnosed in 1995-99: Results of the eurocare-4 study
    • Berrino F, De AR, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, et al.Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83.
    • (2007) Lancet Oncol , vol.8 , pp. 773-783
    • Berrino, F.1    De, A.R.2    Sant, M.3    Rosso, S.4    Bielska-Lasota, M.5    Coebergh, J.W.6
  • 4
    • 0037132795 scopus 로고    scopus 로고
    • Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: Retrospective audit
    • Kirwan JM, Tincello DG, Herod JJ, Frost O, Kingston RE. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. BMJ 2002;324:148-51.
    • (2002) BMJ , vol.324 , pp. 148-151
    • Kirwan, J.M.1    Tincello, D.G.2    Herod, J.J.3    Frost, O.4    Kingston, R.E.5
  • 6
    • 0026771279 scopus 로고    scopus 로고
    • Serous borderline tumors of the ovary: A clinicopathologic, immunohistochemical, and quantitative study of 44 cases
    • de Nictolis M, Montironi R, Tommasoni S, Carinelli S, Ojeda B, Matias-Guiu X, et al. Serous borderline tumors of the ovary: a clinicopathologic, immunohistochemical, and quantitative study of 44 cases. Cancer 2006;70:152-60.
    • (2006) Cancer , vol.70 , pp. 152-160
    • De Nictolis, M.1    Montironi, R.2    Tommasoni, S.3    Carinelli, S.4    Ojeda, B.5    Matias-Guiu, X.6
  • 8
    • 34447526802 scopus 로고    scopus 로고
    • Management of ovarian germ cell tumors
    • Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol 2007;25:2938-43.
    • (2007) J Clin Oncol , vol.25 , pp. 2938-2943
    • Gershenson, D.M.1
  • 9
    • 0023775180 scopus 로고
    • Symptomatology of ovarian cancer
    • Flam F, Einhorn N, Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1988;27:53-7.
    • (1988) Eur J , vol.27 , pp. 53-57
    • Flam, F.1    Einhorn, N.2    Sjovall, K.3
  • 10
    • 33846245932 scopus 로고    scopus 로고
    • Development of an ovarian cancer symptom index: Possibilities for earlier detection
    • Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007;109:221-7.
    • (2007) Cancer , vol.109 , pp. 221-227
    • Goff, B.A.1    Mandel, L.S.2    Drescher, C.W.3    Urban, N.4    Gough, S.5    Schurman, K.M.6
  • 11
    • 0027521105 scopus 로고
    • The adnexal mass: Benign or malignant? evaluation of a risk of malignancy index
    • Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993;100:927-31.
    • (1993) Brj , vol.100 , pp. 927-931
    • Davies, A.P.1    Jacobs, I.2    Woolas, R.3    Fish, A.4    Oram, D.5
  • 12
    • 56749173383 scopus 로고    scopus 로고
    • A longitudinal investigation of psychological morbidity in patients with ovarian cancer
    • Goncalves V, Jayson G, Tarrier N. A longitudinal investigation of psychological morbidity in patients with ovarian cancer. Br J Cancer 2008;99:1794-801.
    • (2008) Brj Cancer , vol.99 , pp. 1794-1801
    • Goncalves, V.1    Jayson, G.2    Tarrier, N.3
  • 14
    • 66849097259 scopus 로고    scopus 로고
    • Current figo staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia
    • Kavanagh JJ, Pecorelli S, Benedetti JL. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynecol Obstet 2009;105:3-4.
    • (2009) Int J Gynecol , vol.105 , pp. 3-4
    • Kavanagh, J.J.1    Pecorelli, S.2    Benedetti, J.L.3
  • 15
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
    • Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-4.
    • (1975) Natl Cancer Inst Monogr , vol.42 , pp. 101-104
    • Griffiths, C.T.1
  • 16
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
    • (2002) J Clin Oncol , vol.20 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3    Trimble, E.L.4    Montz, F.J.5
  • 17
    • 34548491626 scopus 로고    scopus 로고
    • Prognostic factors for stage iii epithelial ovarian cancer: A gynecologic oncology group study
    • Winter WE III, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:3621-7.
    • (2007) J Clin Oncol , vol.25 , pp. 3621-3627
    • Winter, W.1    Maxwell, G.L.2    Tian, C.3    Carlson, J.W.4    Ozols, R.F.5    Rose, P.G.6
  • 18
    • 38649086712 scopus 로고    scopus 로고
    • The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer
    • Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 2008;108:276-81.
    • (2008) Gynecol Oncol , vol.108 , pp. 276-281
    • Eisenhauer, E.L.1    Abu-Rustum, N.R.2    Sonoda, Y.3    Aghajanian, C.4    Barakat, R.R.5    Chi, D.S.6
  • 19
    • 37849025830 scopus 로고    scopus 로고
    • Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage iv epithelial ovarian cancer: A gynecologic oncology group study
    • Winter WE III, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2008;26:83-9.
    • (2008) J Clin Oncol , vol.26 , pp. 83-89
    • Winter, W.1    Maxwell, G.L.2    Tian, C.3    Sundborg, M.J.4    Rose, G.S.5    Rose, P.G.6
  • 20
    • 0041622805 scopus 로고    scopus 로고
    • Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study
    • Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003;90:390-6.
    • (2003) Gynecol Oncol , vol.90 , pp. 390-396
    • Eisenkop, S.M.1    Spirtos, N.M.2    Friedman, R.L.3    Lin, W.C.4    Pisani, A.L.5    Perticucci, S.6
  • 21
    • 0032077205 scopus 로고    scopus 로고
    • Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
    • Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103-8.
    • (1998) Gynecol Oncol , vol.69 , pp. 103-108
    • Eisenkop, S.M.1    Friedman, R.L.2    Wang, H.J.3
  • 22
    • 34548140650 scopus 로고    scopus 로고
    • Multivisceral cytoreductive surgery in figo stages iiic and iv epithelial ovarian cancer: Results and 5-year follow-up
    • Scholz HS, Tasdemir H, Hunlich T, Turnwald W, Both A, Egger H. Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up. Gynecol Oncol 2007;106:591-5.
    • (2007) Gynecol Oncol , vol.106 , pp. 591-595
    • Scholz, H.S.1    Tasdemir, H.2    Hunlich, T.3    Turnwald, W.4    Both, A.5    Egger, H.6
  • 23
    • 20244376152 scopus 로고    scopus 로고
    • Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
    • Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005;97:560-6.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 560-566
    • Panici, P.B.1    Maggioni, A.2    Hacker, N.3    Landoni, F.4    Ackermann, S.5    Campagnutta, E.6
  • 26
    • 0028952438 scopus 로고
    • The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the european organization for research and treatment of cancer
    • van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-34.
    • (1995) Nengl J Med , vol.332 , pp. 629-634
    • Van Der Burg, M.E.1    Van Lent, M.2    Buyse, M.3    Kobierska, A.4    Colombo, N.5    Favalli, G.6
  • 28
    • 57649183685 scopus 로고    scopus 로고
    • Interval debulking surgery for advanced epithelial ovarian cancer: A cochrane systematic review
    • Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol 2009 Jan;112(1):257-64.
    • (2009) Gynecol Oncol , vol.112 , Issue.1 , pp. 257-264
    • Tangjitgamol, S.1    Manusirivithaya, S.2    Laopaiboon, M.3    Lumbiganon, P.4
  • 29
    • 67651158840 scopus 로고    scopus 로고
    • Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review
    • Gerestein CG, Damhuis RA, Burger CW, Kooi GS. Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review. Gynecol Oncol 2009;114:523-7.
    • (2009) Gynecol Oncol , vol.114 , pp. 523-527
    • Gerestein, C.G.1    Damhuis, R.A.2    Burger, C.W.3    Kooi, G.S.4
  • 32
    • 0037440317 scopus 로고    scopus 로고
    • International collaborative ovarian neoplasm trial 1: A randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer
    • Colombo N, Guthrie D, Chiari S, Parmar M, Qian W, Swart AM, et al. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003;95:125-32.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 125-132
    • Colombo, N.1    Guthrie, D.2    Chiari, S.3    Parmar, M.4    Qian, W.5    Swart, A.M.6
  • 33
    • 0037440295 scopus 로고    scopus 로고
    • Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer adjuvant chemotherapy in ovarian neoplasm trial
    • Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 113-125
    • Trimbos, J.B.1    Vergote, I.2    Bolis, G.3    Vermorken, J.B.4    Mangioni, C.5    Madronal, C.6
  • 34
    • 0037440207 scopus 로고    scopus 로고
    • International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: Two parallel randomized phase iii trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma
    • Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 105-112
    • Trimbos, J.B.1    Parmar, M.2    Vergote, I.3    Guthrie, D.4    Bolis, G.5    Colombo, N.6
  • 36
    • 0035915662 scopus 로고    scopus 로고
    • Prognostic importance of degree of differentiation and cyst rupture in stage i invasive epithelial ovarian carcinoma
    • Vergote I, De BJ, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176-82.
    • (2001) Lancet , vol.357 , pp. 176-182
    • Vergote, I.1    De, B.J.2    Fyles, A.3    Bertelsen, K.4    Einhorn, N.5    Sevelda, P.6
  • 37
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage iii and stage iv ovarian cancer
    • McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
    • (1996) Nengl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3    Kucera, P.R.4    Partridge, E.E.5    Look, K.Y.6
  • 38
    • 0034600305 scopus 로고    scopus 로고
    • Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin- cyclophosphamide in women with advanced epithelial ovarian cancer: Three- year results
    • Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin- cyclophosphamide in women with advanced epithelial ovarian cancer: three- year results. J Natl Cancer Inst 2000;92:699-708.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 699-708
    • Piccart, M.J.1    Bertelsen, K.2    James, K.3    Cassidy, J.4    Mangioni, C.5    Simonsen, E.6
  • 39
    • 33645781536 scopus 로고    scopus 로고
    • Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: A systematic review and economic evaluation
    • Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. Health Technol Assess 2006;10(9):1-132.
    • (2006) Health Technol Assess , vol.10 , Issue.9 , pp. 1-132
    • Main, C.1    Bojke, L.2    Griffin, S.3    Norman, G.4    Barbieri, M.5    Mather, L.6
  • 41
    • 0037862963 scopus 로고    scopus 로고
    • Paclitaxel plus platinum-based chemotherapy versus conventional platinum- based chemotherapy in women with relapsed ovarian cancer: The icon4/ago- ovar-2.2 trial
    • Parmar MK, Ledermann JA, Colombo N, du BA, Delaloye JF, Kristensen GB, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum- based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO- OVAR-2.2 trial. Lancet 2003;361:2099-106.
    • (2003) Lancet , vol.361 , pp. 2099-2106
    • Parmar, M.K.1    Ledermann, J.A.2    Colombo, N.3    Du, B.A.4    Delaloye, J.F.5    Kristensen, G.B.6
  • 42
    • 33845657404 scopus 로고    scopus 로고
    • Surgery in recurrent ovarian cancer: The arbeitsgemeinschaft gynaekologische onkologie (ago) desktop ovar trial
    • Harter P, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 2006;13:1702-10.
    • (2006) Ann Surg Oncol , vol.13 , pp. 1702-1710
    • Harter, P.1    Du Bois, A.2    Hahmann, M.3    Hasenburg, A.4    Burges, A.5    Loibl, S.6
  • 45
    • 0029910164 scopus 로고    scopus 로고
    • Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature
    • Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Cancer 1996;78:2049-62.
    • (1996) Cancer , vol.78 , pp. 2049-2062
    • Bristow, R.E.1    Lagasse, L.D.2    Karlan, B.Y.3
  • 46
    • 33645329606 scopus 로고    scopus 로고
    • Routine follow-up after treatment for a gynecological cancer: A survey of practice
    • Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer 2006;16:380-4.
    • (2006) Int J Gynecol Cancer , vol.16 , pp. 380-384
    • Kew, F.M.1    Cruickshank, D.J.2
  • 47
    • 68749099837 scopus 로고    scopus 로고
    • A randomized trial in ovarian cancer (Oc) of early treatment of relapse based on ca125level alone versus delayed treatment based on conventional clinical indicators (mrc ov05/eortc 55955 trials)
    • Rustin GJ, van der Burg ME, on behalf of MRC and EORTC collaborators. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). Int J Clin Oncol 2009;27 Suppl:18.
    • (2009) Int J Clin Oncol , pp. 18
    • Rustin, G.J.1    Van Der Burg, M.E.2
  • 49
    • 63149087256 scopus 로고    scopus 로고
    • Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the uk collaborative trial of ovarian cancer screening (ukctocs)
    • Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327-40.
    • (2009) Lancet Oncol , vol.10 , pp. 327-340
    • Menon, U.1    Gentry-Maharaj, A.2    Hallett, R.3    Ryan, A.4    Burnell, M.5    Sharma, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.